4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-17-010787
$NBYCIK 0001389545operating
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 5:34 PM ET
Size
5.8 KB
Accession
0001437749-17-010787
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
stock option (right to buy)
2017-06-02+250,000→ 250,000 totalExercise: $2.35From: 2017-01-31Exp: 2027-06-02→ common stock (250,000 underlying)
Footnotes (3)
- [F1]Granted pursuant to the 2017 Omnibus Incentive Plan
- [F2]Granted pursuant to the employment agreement signed between Company and Executive on June 2, 2017.
- [F3]One-fourth (1/4) of the shares subject to the Option will vest on January 31, 2018, in direct proportion to the percentage achievement of the stated 2017 corporate goals, as approved and determined by the Board. The remaining three-fourths (3/4) of the shares subject to the Option shall vest in equal parts on January 31, 2019, January 31, 2020 and January 31, 2021, in direct proportion to the percentage achievement of the stated corporate goals for the previous fiscal year of such date. The Option will be fully vested and exercisable on January 31, 2021, subject to Mr. Sieczkarek continuing to be an employee (or otherwise providing services to the Company) through the relevant vesting dates.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 5:34 PM ET
- Size
- 5.8 KB